103 related articles for article (PubMed ID: 24912162)
1. IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for Toll-like receptor activation of ERK-1 and -2 MAP kinases.
Ben-Addi A; Mambole-Dema A; Brender C; Martin SR; Janzen J; Kjaer S; Smerdon SJ; Ley SC
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2394-403. PubMed ID: 24912162
[TBL] [Abstract][Full Text] [Related]
2. NF-κB1 inhibits TLR-induced IFN-β production in macrophages through TPL-2-dependent ERK activation.
Yang HT; Wang Y; Zhao X; Demissie E; Papoutsopoulou S; Mambole A; O'Garra A; Tomczak MF; Erdman SE; Fox JG; Ley SC; Horwitz BH
J Immunol; 2011 Feb; 186(4):1989-96. PubMed ID: 21217011
[TBL] [Abstract][Full Text] [Related]
3. ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses.
Papoutsopoulou S; Symons A; Tharmalingham T; Belich MP; Kaiser F; Kioussis D; O'Garra A; Tybulewicz V; Ley SC
Nat Immunol; 2006 Jun; 7(6):606-15. PubMed ID: 16633345
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation.
Park HD; Lee Y; Oh YK; Jung JG; Park YW; Myung K; Kim KH; Koh SS; Lim DS
Oncogene; 2011 Jan; 30(2):201-11. PubMed ID: 20802527
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide.
Dhungana S; Merrick BA; Tomer KB; Fessler MB
Mol Cell Proteomics; 2009 Jan; 8(1):201-13. PubMed ID: 18815123
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3 proteins facilitate the activation of MAP kinase cascades by upstream immunity-related kinases.
Dong X; Feng F; Li Y; Li L; Chen S; Zhou JM
Plant Cell; 2023 May; 35(6):2413-2428. PubMed ID: 36943771
[TBL] [Abstract][Full Text] [Related]
7. IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell-dependent antigen.
Jacque E; Schweighoffer E; Visekruna A; Papoutsopoulou S; Janzen J; Zillwood R; Tarlinton DM; Tybulewicz VL; Ley SC
J Exp Med; 2014 Sep; 211(10):2085-101. PubMed ID: 25225457
[TBL] [Abstract][Full Text] [Related]
8. TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.
Xiao Y; Jin J; Chang M; Nakaya M; Hu H; Zou Q; Zhou X; Brittain GC; Cheng X; Sun SC
J Exp Med; 2014 Jul; 211(8):1689-702. PubMed ID: 24980047
[TBL] [Abstract][Full Text] [Related]
9. TLR and TNF-R1 activation of the MKK3/MKK6-p38α axis in macrophages is mediated by TPL-2 kinase.
Pattison MJ; Mitchell O; Flynn HR; Chen CS; Yang HT; Ben-Addi H; Boeing S; Snijders AP; Ley SC
Biochem J; 2016 Sep; 473(18):2845-61. PubMed ID: 27402796
[TBL] [Abstract][Full Text] [Related]
10. Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus.
Kuriakose T; Tripp RA; Watford WT
PLoS Pathog; 2015 Aug; 11(8):e1005038. PubMed ID: 26241898
[TBL] [Abstract][Full Text] [Related]
11. Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.
Lee HW; Choi HY; Joo KM; Nam DH
Int J Mol Sci; 2015 Feb; 16(3):4471-91. PubMed ID: 25723737
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.
Kuriakose T; Rada B; Watford WT
J Biol Chem; 2014 Dec; 289(52):36089-100. PubMed ID: 25378393
[TBL] [Abstract][Full Text] [Related]
13. Priming IKKβ kinase for action.
Ley SC; Beyaert R
Biochem J; 2014 Oct; 463(1):e1-2. PubMed ID: 25195736
[TBL] [Abstract][Full Text] [Related]
14. Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis.
Nurmi K; Silventoinen K; Keskitalo S; Rajamäki K; Kouri VP; Kinnunen M; Jalil S; Maldonado R; Wartiovaara K; Nievas EI; Denita-Juárez SP; Duncan CJA; Kuismin O; Saarela J; Romo I; Martelius T; Parantainen J; Beklen A; Bilicka M; Matikainen S; Nordström DC; Kaustio M; Wartiovaara-Kautto U; Kilpivaara O; Klein C; Hauck F; Jahkola T; Hautala T; Varjosalo M; Barreto G; Seppänen MRJ; Eklund KK
Cell Rep Med; 2024 Apr; 5(4):101503. PubMed ID: 38593810
[TBL] [Abstract][Full Text] [Related]
15. ERK1/2 in immune signalling.
Lucas RM; Luo L; Stow JL
Biochem Soc Trans; 2022 Oct; 50(5):1341-1352. PubMed ID: 36281999
[TBL] [Abstract][Full Text] [Related]
16. TPL-2 Inhibits IFN-β Expression via an ERK1/2-TCF-FOS Axis in TLR4-Stimulated Macrophages.
Blair L; Pattison MJ; Chakravarty P; Papoutsopoulou S; Bakiri L; Wagner EF; Smale S; Ley SC
J Immunol; 2022 Feb; 208(4):941-954. PubMed ID: 35082159
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic
Bansod S; Dodhiawala PB; Lim KH
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771644
[TBL] [Abstract][Full Text] [Related]
18. The role of 14-3-3 proteins in cell signalling pathways and virus infection.
Liu J; Cao S; Ding G; Wang B; Li Y; Zhao Y; Shao Q; Feng J; Liu S; Qin L; Xiao Y
J Cell Mol Med; 2021 May; 25(9):4173-4182. PubMed ID: 33793048
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer.
Khurana N; Dodhiawala PB; Bulle A; Lim KH
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32961746
[TBL] [Abstract][Full Text] [Related]
20. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
Dodhiawala PB; Khurana N; Zhang D; Cheng Y; Li L; Wei Q; Seehra K; Jiang H; Grierson PM; Wang-Gillam A; Lim KH
J Clin Invest; 2020 Sep; 130(9):4771-4790. PubMed ID: 32573499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
